Sparta Commercial Services (SRCO) 10-Q 20 Dec 23 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Oct. 31, 2023	Dec. 20, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Oct. 31, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--04-30
Entity File Number	0-9483
Entity Registrant Name	SPARTA COMMERCIAL SERVICES, INC.
Entity Central Index Key	0000318299
Entity Tax Identification Number	30-0298178
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	555 Fifth Avenue
Entity Address, Address Line Two	14th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	(212)
Local Phone Number	239-2666
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	SRCO
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		25,120,280

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Oct. 31, 2023	Apr. 30, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 4,562	$ 4,028
Accounts Receivable	870
Inventory	2,022
TOTAL CURRENT ASSETS	7,454	4,028
NON-CURRENT ASSETS
Rent Deposit	9,000	9,000
Property and equipment, net of accumulated depreciation and amortization
TOTAL NON-CURRENT ASSETS	9,000	9,000
TOTAL ASSETS	16,454	13,028
CURRENT LIABILITIES
Bank Overdraft	55,298	54,410
Short Term Loan	1,585	1,585
Accounts Payable and Accrued expenses	1,554,397	1,698,457
Derivative Liability	1,198,394	1,375,767
Notes Payable	7,114,187	6,694,245
TOTAL CURRENT LIABILITIES	9,923,861	9,824,464
NON-CURRENT LIABILITIES
Loans Payable	631,163	435,753
TOTAL NON-CURRENT LIABILITIES	631,163	435,753
TOTAL LIABILITIES	10,555,024	10,260,217
STOCKHOLDER’S DEFICIT:
Common stock, $0.001 par value; 750,000,000 shares authorized, and 23,323,456 and 23,045,205 shares issued and outstanding as of October 31, 2023 and April 30, 2023, respectively	24,323	23,045
Common stock to be issued 24,701,437 and 23,704,788 respectively	24,702	23,705
Additional paid-in capital	55,149,603	54,872,206
Accumulated deficit	(66,726,591)	(66,150,857)
TOTAL DEFICIENCY IN STOCKHOLDER’S EQUITY	(11,512,546)	(11,216,484)
Non-Controlling Interest	973,976	969,295
TOTAL DEFICIT	(10,538,570)	(10,247,189)
TOTAL LIABILITIES AND EQUITY	16,454	13,028
Series A Convertible Preferred Stock [Member]
STOCKHOLDER’S DEFICIT:
Preferred stock, value	12,500	12,500
Series C Preferred Stock [Member]
STOCKHOLDER’S DEFICIT:
Preferred stock, value	1,979	1,979
Series D Preferred Stock [Member]
STOCKHOLDER’S DEFICIT:
Preferred stock, value	$ 938	$ 938

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Oct. 31, 2023	Apr. 30, 2023
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	750,000,000	750,000,000
Common stock shares issued	23,323,456	23,045,205
Common stock shares outstanding	23,323,456	23,045,205
Common stock to be issued	24,701,437	23,704,788
Series A Convertible Preferred Stock [Member]
Preferred stock, par value	$ 100	$ 100
Preferred stock, shares designated	35,850	35,850
Preferred stock, shares issued	125	125
Preferred stock, shares outstanding	125	125
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	4,200,000	4,200,000
Preferred stock, shares issued	1,979,157	1,979,157
Preferred stock, shares outstanding	1,979,157	1,979,157
Preferred stock, liquidation and redemption value per share	$ 1	$ 1
Series D Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	2,000,000	2,000,000
Preferred stock, shares issued	937,754	937,754
Preferred stock, shares outstanding	937,754	937,754
Preferred stock, liquidation and redemption value per share	$ 1	$ 1

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenue
Total Revenue	$ 52,418	$ 56,419	$ 114,697	$ 125,372
Less: Cost of goods sold	14,135	11,802	23,059	22,845
Gross Profit	38,283	44,617	91,638	102,527
Operating Expenses
Compensation and related cost	138,697	177,856	299,792	345,686
Consulting fee	14,400	21,500	34,890	23,000
Rent and lease	18,000	16,350	36,000	32,600
Accounting and legal fees	44,510	43,483	45,650	333,390
General office expenses	89,239	45,657	203,551	143,052
Total Operating Expenses	304,846	304,846	619,883	877,728
Income/(Loss) from Operations	(266,563)	(260,229)	(528,245)	(775,201)
Other Income/(Expense)
Commission on municipal bonds	3,166		3,897
Financing cost	(144,481)	(1,280)	(284,867)	(2,305)
Write off convertible notes	21,364	950,033	60,789	950,033
Gain/(Loss) in changes in fair value of derivative liability	24,095	1,666,563	177,373	3,287,835
Total Other Income/(Expense)	(95,856)	2,615,316	(42,808)	4,235,563
Net Income (Loss)	(362,419)	2,355,087	(571,053)	3,460,362
Net income (loss) attributable to minority shareholders	(1,972)	(2,789)	(4,681)	(6,713)
Net income (loss) attributed to common stockholders	$ (364,391)	$ 2,352,298	$ (575,734)	$ 3,453,649
Net Income (loss) per share - Sparta Common share holder, basic	$ (0.015)	$ 0.129	$ (0.024)	$ 0.200
Net Income (loss) per share - Sparta Common share holder, diluted	$ (0.015)	$ 0.129	$ (0.024)	$ 0.200
Weighted average shares outstanding, basic	24,323,456	18,196,367	24,323,456	17,268,356
Weighted average shares outstanding, diluted	24,323,456	18,196,367	24,323,456	17,268,356
Information Technology [Member]
Revenue
Total Revenue	$ 42,875	$ 49,972	$ 98,071	$ 113,439
New World Health Brands [Member]
Revenue
Total Revenue	$ 9,543	$ 6,447	$ 16,626	$ 11,933

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders' Deficits (Unaudited) - USD ($)	Series A Preferred Stock [Member] Preferred Stock [Member]	Series C Preferred Stock [Member] Preferred Stock [Member]	Series D Preferred Stock [Member] Preferred Stock [Member]	Common Stock [Member]	Common Stock to be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Apr. 30, 2022	$ 12,500	$ 2,363	$ 618	$ 15,128	$ 8,292	$ 53,210,921	$ (73,984,686)	$ 984,175	$ (19,750,689)
Beginning balance, shares at Apr. 30, 2022	125	2,163,000	618,411	15,128,005	8,916,805
Issuance of common shares for cash					$ 1,824	93,175			94,999
Issuance of common shares for cash, shares					1,824,771
Issuance of shares for equity				$ 518		44,128			44,646
Stocks issued for equity, shares				518,333
Net income (loss) for the quarter							1,101,351	3,924	1,105,275
Issuance of shares for services				$ 1,595		243,786			245,381
Issuance of shares for services, shares				1,594,960
Conversion of Preferred to common shares		$ (60)		$ 60		9,940			9,940
Conversion of Preferred to common shares, shares		(60,000)		60,000
Ending balance, value at Jul. 31, 2022	$ 12,500	$ 2,303	$ 618	$ 17,301	$ 10,116	53,601,950	(72,883,335)	988,099	(18,250,448)
Ending balance, shares at Jul. 31, 2022	125	2,103,000	618,411	17,301,298	10,741,576
Beginning balance, value at Apr. 30, 2022	$ 12,500	$ 2,363	$ 618	$ 15,128	$ 8,292	53,210,921	(73,984,686)	984,175	(19,750,689)
Beginning balance, shares at Apr. 30, 2022	125	2,163,000	618,411	15,128,005	8,916,805
Net income (loss) for the quarter									3,460,362
Ending balance, value at Oct. 31, 2022	$ 12,500	$ 1,722	$ 477	$ 18,701	$ 10,622	53,933,335	(70,531,037)	990,888	(15,562,792)
Ending balance, shares at Oct. 31, 2022	125	1,522,000	477,411	18,700,782	11,247,437
Beginning balance, value at Jul. 31, 2022	$ 12,500	$ 2,303	$ 618	$ 17,301	$ 10,116	53,601,950	(72,883,335)	988,099	(18,250,448)
Beginning balance, shares at Jul. 31, 2022	125	2,103,000	618,411	17,301,298	10,741,576
Issuance of common shares for cash				$ 135	$ 506	49,359			50,000
Issuance of common shares for cash, shares				134,805	505,861
Stocks issued as a note holder incentive				$ 213		19,388			19,601
Stocks issued as a note holder incentive, shares				212,500
Issuance of shares for equity				$ 330		24,670			25,000
Stocks issued for equity, shares				330,179
Net income (loss) for the quarter							2,352,298	2,789	2,355,087
Conversion of Preferred to common shares C		$ (581)		$ 581		96,915			96,915
Conversion of Preferred to common shares C, shares		(581,000)		581,000
Conversion of Preferred to common shares D			$ (141)	$ 141		141,053			141,053
Conversion of Preferred to common shares D, shares			(141,000)	141,000
Ending balance, value at Oct. 31, 2022	$ 12,500	$ 1,722	$ 477	$ 18,701	$ 10,622	53,933,335	(70,531,037)	990,888	(15,562,792)
Ending balance, shares at Oct. 31, 2022	125	1,522,000	477,411	18,700,782	11,247,437
Beginning balance, value at Apr. 30, 2023	$ 12,500	$ 1,979	$ 938	$ 23,045	$ 23,705	54,872,206	(66,150,857)	969,295	(10,247,189)
Beginning balance, shares at Apr. 30, 2023	125	1,979,157	937,701	23,045,205	23,704,788
Issuance of common shares for cash					$ 1,133	103,867			105,000
Issuance of common shares for cash, shares					1,133,000
Stocks issued as a note holder incentive				$ 75		6,900			6,975
Stocks issued as a note holder incentive, shares				75,000
Issuance of shares for equity				$ 831	$ (831)	69,169			69,169
Stocks issued for equity, shares				830,906	(830,906)
Net income (loss) for the quarter							(211,343)	2,709	(208,634)
Ending balance, value at Jul. 31, 2023	$ 12,500	$ 1,979	$ 938	$ 23,951	$ 24,007	55,052,142	(66,362,200)	972,004	(10,274,679)
Ending balance, shares at Jul. 31, 2023	125	1,979,157	937,701	23,951,111	24,006,882
Beginning balance, value at Apr. 30, 2023	$ 12,500	$ 1,979	$ 938	$ 23,045	$ 23,705	54,872,206	(66,150,857)	969,295	(10,247,189)
Beginning balance, shares at Apr. 30, 2023	125	1,979,157	937,701	23,045,205	23,704,788
Net income (loss) for the quarter									(571,053)
Ending balance, value at Oct. 31, 2023	$ 12,500	$ 1,979	$ 938	$ 24,323	$ 24,702	55,149,603	66,726,591	973,976	(10,538,570)
Ending balance, shares at Oct. 31, 2023	125	1,979,157	937,701	24,323,106	24,701,887
Beginning balance, value at Jul. 31, 2023	$ 12,500	$ 1,979	$ 938	$ 23,951	$ 24,007	55,052,142	(66,362,200)	972,004	(10,274,679)
Beginning balance, shares at Jul. 31, 2023	125	1,979,157	937,701	23,951,111	24,006,882
Issuance of common shares for cash					$ 988	64,012			65,000
Issuance of common shares for cash, shares					988,000
Stocks issued as a note holder incentive					$ 54	4,946			5,000
Stocks issued as a note holder incentive, shares					54,000
Issuance of shares for equity				$ 347	$ (347)	24,653			24,653
Stocks issued for equity, shares				346,995	(346,995)
Net income (loss) for the quarter							(364,391)	1,972	(362,419)
Issuance of shares for services				$ 25		3,850			3,875
Issuance of shares for services, shares				25,000
Ending balance, value at Oct. 31, 2023	$ 12,500	$ 1,979	$ 938	$ 24,323	$ 24,702	$ 55,149,603	$ 66,726,591	$ 973,976	$ (10,538,570)
Ending balance, shares at Oct. 31, 2023	125	1,979,157	937,701	24,323,106	24,701,887

Condensed Consolidated Statem_3

Condensed Consolidated Statements Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (loss)	$ (571,053)	$ 3,460,362
Adjustments to reconcile net loss to net cash used in operating activities:
Loss (Gain) from change in fair value of derivative liabilities	(177,373)	(3,287,835)
Financing cost	284,867	377
Stock based compensation		581,324
Forgiveness of debt	(60,789)	(950,033)
Changes in operating assets and liabilities
Accounts receivable	(870)	(43,314)
Inventory	(2,022)	4,291
Accounts payable and accrued expenses	(144,060)	(127,669)
Accrued interest	231,485
Net cash used in operating activities	(439,815)	(362,497)
CASH FLOWS FROM FINANCING ACTIVITIES
Bank overdraft	888	22,014
Stock issued for equity	105,461
Proceeds from sale of stock	175,000	144,999
Proceeds from related party notes		8,100
Net Proceeds from notes payable	159,000	188,452
Net cash provided by financing activities	440,349	363,565
Net (decrease) increase in cash	534	1,068
Cash and cash equivalents, beginning of period	4,028	317
Cash and cash equivalents, end of period	4,562	$ 1,385
Supplemental Non cash financing activities:
Adjustments to related party notes	(196,156)
Modifications to Notes Payable	427,642
TOTAL non cash financing activities	$ 231,485

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE A – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES A summary of the significant accounting policies applied in the preparation of the accompanying unaudited condensed consolidated financial statements follows. Business General Overview Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation with headquarters in New York City. We are a multi-disciplined parent corporation operating across three business sectors – Financial Services, E-Commerce & Mobile Technology, and Health and Wellness. Sparta’s roots are in the Powersports industry. The Company provided retail installment loans and leases through authorized motorcycle dealerships in 33 states, with financing lines of credit provided by institutional lenders. In 2007, the Company introduced a Municipal Financing program which has financed over 100 jurisdictions to date. Vehicle History Reports are a staple of Sparta’s E-Commerce Technology subsidiary iMobile Solutions, Inc. Whether a vehicle is intended for business or recreational use, Sparta’s Vehicle History Reports are highly regarded for accuracy and completeness and have been sold across all 50 states and in 62 countries worldwide. With iMobile App, the Company provides mobile technology services, including web and mobile application creation, development and management, text messaging services, CRM (Customer Relationship Management) tools, and custom kitchen ordering systems for a wide range of businesses to increase revenue, build brand recognition, and improve customer engagement. Sparta’s subsidiary, New World Health Brands, Inc., offers high quality dietary supplements Sparta’s subsidiary, Sparta Crypto, Inc., is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services; and has completed and tested a cryptocurrency payment gateway called SpartaPayIQ. Agoge Global USA, Inc. (“Agoge”). Agoge was formed as a subsidiary of Sparta Crypto, Inc. in December 2022 and entered in to a Joint Venture Agreement with WeDev Group of Brazil to facilitate cross-border transactions between importers and exporters of goods from the U.S. and Brazil. Basis of Presentation The accompanying unaudited condensed consolidated financial statements as of October 31, 2023 and for the six months ended October 31, 2023 and 2022 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, including Form 10-Q and Regulation S-K. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments), which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. The Company believes that the disclosures provided are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and explanatory notes for the year ended April 30, 2023 as disclosed in the Company’s Form 10-K for that year as filed with the Securities and Exchange Commission on August 15, 2023. The results of operations for the six months ended October 31, 2023 are not necessarily indicative of the results to be expected for any other interim period or the full year ending April 30, 2023. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation. The third-party ownership of the Company’s subsidiary is accounted for as non-controlling interest in the consolidated financial statements. Changes in the non-controlling interest are reported in the statement of changes in deficit. Estimates These financial statements have been prepared in accordance with accounting principles generally accepted in United States of America which require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and the disclosures of revenues and expenses for the reported period. Accordingly, actual results could differ from those estimates. Revenue Recognition The Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions. Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable. Cash Equivalents For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. Fair Value Measurements The Company has adopted ASC 820, “Fair Value Measurements .” ● Level 1 — ● Level 2 — ● Level 3 — This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available. Income Taxes We utilize ASC 740 “ Income Taxes The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense. Stock Based Compensation We account for our stock-based compensation under ASC 718 “ Compensation – Stock Compensation We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. Inventories The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health business. Property and Equipment Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows: SCHEDULE OF ESTIMATED USEFUL OF PROPERTY AND EQUIPMENT Leasehold improvements 3 years Furniture and fixtures 7 years Website costs 3 years Computer Equipment 5 years Estimated Useful of Property and Equipment 5 years Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit. Net Loss Per Share The Company uses ASC 260-10, “ Earnings Per Share Derivative Liabilities The Company assessed the classification of its derivative financial instruments as of October 31, 2023 and April 30, 2023, which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described. Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “ Accounting for Derivative Instruments and Hedging Activities The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “ Accounting for Convertible Securities with Beneficial Conversion Features Reclassifications Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses. Recent Accounting Pronouncements No recent pronouncements have been made or adopted in the quarter ended October 31, 2023. All of the pronouncements that affect our business have been adopted.

GOING CONCERN MATTERS

GOING CONCERN MATTERS	6 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN MATTERS	NOTE B – GOING CONCERN MATTERS The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying unaudited condensed consolidated financial statements, the Company has incurred recurring losses and generated negative cash flows from operating activities since inception. As of October 31, 2023, the Company had an accumulated deficit of $ 66,726,591 9,901,600 The Company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that the Company’s efforts will be successful. No assurance can be given that management’s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern. In order to improve the Company’s liquidity, the Company’s management is actively pursuing additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing.

NOTES PAYABLE AND DERIVATIVES

NOTES PAYABLE AND DERIVATIVES	6 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
NOTES PAYABLE AND DERIVATIVES	NOTE C – NOTES PAYABLE AND DERIVATIVES The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of 5 20 SCHEDULE OF NOTES PAYABLE Notes Payable October 31, 2023 April 30, 2023 Notes convertible at holder’s option $ 2,845,109 $ 3,112,734 Notes convertible at Company’s option 335,700 335,700 Non-convertible notes payable 2,383,308 1,861,650 Subtotal 5,564,117 5,310,084 Debt discount - - Total $ 5,564,117 $ 5,310,084 Certain of the notes payable contain variable conversion rates and the conversion features are classified as derivative liabilities. The conversion prices are based on the market price of the Company’s common stock, at discounts of 30 48 The Company’s derivative financial instruments consist of embedded derivatives related to the outstanding short-term Convertible Notes Payable. These embedded derivatives include certain conversion features indexed to the Company’s common stock. The accounting treatment of derivative financial instruments requires that the Company record the derivatives and related items at their fair values as of the inception date of the Convertible Notes Payable and at fair value as of each subsequent balance sheet date. In addition, under the provisions of Accounting Standards Codification subtopic 815-40, Derivatives and Hedging; Contracts in Entity’s Own Equity (“ASC 815-40”), as a result of entering into the Convertible Notes Payable, the Company is required to classify all other non-employee stock options and warrants as derivative liabilities and mark them to market at each reporting date. Any change in fair value inclusive of modifications of terms will be recorded as non-operating, non-cash income or expense at each reporting date. If the fair value of the derivatives is higher at the subsequent balance sheet date, the Company will record a non-operating, non-cash charge. If the fair value of the derivatives is lower at the subsequent balance sheet date, the Company will record non-operating, non-cash income. The change in fair value of the derivative liabilities at October 31, 2023 was calculated with the following average assumptions, using a Black-Scholes option pricing model are as follows: SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION Significant Assumptions: Risk free interest rate Ranging from 0.16 0.2 % Expected stock price volatility Ranging from 155 270 % Expected dividend payout 0 Expected life in years Ranging from 0.25 3.0 Changes in derivative liability during the three months ended October 31, 2023 and 2022 were: SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES 2023 2022 October 31, 2023 2022 Balance, beginning of year $ 1,375,767 $ 9,549,640 Derivative liability extinguished (100,797 ) (336,418 ) Fair value adjustments (76,576 ) (3,287,385 ) Balance, end of period 1,198,394 $ 5,925,387

LOANS PAYABLE TO RELATED PARTIE

LOANS PAYABLE TO RELATED PARTIES	6 Months Ended
	Oct. 31, 2023
Related Party Transactions [Abstract]
LOANS PAYABLE TO RELATED PARTIES	NOTE D – LOANS PAYABLE TO RELATED PARTIES As of October 31, 2023, and April 30, 2023, aggregated loans and notes payable, without demand and with no interest, to officers, directors, and other related parties were $ 631,163 435,753

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS	6 Months Ended
	Oct. 31, 2023
Equity [Abstract]
EQUITY TRANSACTIONS	NOTE E – EQUITY TRANSACTIONS Preferred Stock The Company is authorized to issue 10,000,000 0.001 35,850 100 1,000 10,000 4,200,000 1.00 2,000,000 1 Common Stock The Company is authorized to issue 750,000,000 0.001 24,323,456 23,045,205 During the six months ended October 31, 2023, the Company: ● Issued 1,178,251 95,000 ● Issued 25,000 3,875 ● Issued 75,000 6,975 ● Sold to five accredited investors 1,127,372 85,000 During the six months ended October 31, 2022, the Company: ● Sold 134,805 50,000 ● Issued 641,000 ● Issued 141,000 ● Issued 212,500 shares ● Issued 1,594,960 shares for consulting services

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE F – FAIR VALUE MEASUREMENTS The Company follows the guidance established pursuant to ASC 820 which established a framework for measuring fair value and expands disclosure about fair value measurements. ASC 820 defines fair value as the amount that would be received for an asset or paid to transfer a liability (i.e., an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes the following three levels of inputs that may be used: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets and liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data. Level 3: Unobservable inputs when there is little or no market data available, thereby requiring an entity to develop its own assumptions. The fair value hierarchy gives the lowest priority to Level 3 inputs. The table below summarizes the fair values of financial liabilities as of October 31, 2023: SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES Fair Value at Fair Value Measurement Using October 31, 2023 Level 1 Level 2 Level 3 Derivative liabilities $ 1,198,394 - - $ 1,198,394 Fair values of financial liabilities as of April 30, 2023 are as follows: Fair Value at Fair Value Measurement Using April 30, 2023 Level 1 Level 2 Level 3 Derivative liabilities $ 1,375,767 - - $ 1,375,767 The following is a description of the valuation methodologies used for these items: Derivative liabilities The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value in accordance with ASC Topic 825 “ The Fair Value Option for Financial Issuances

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	6 Months Ended
	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE G – PROPERTY AND EQUIPMENT Major classes of property and equipment at October 31, 2023 and April 30, 2023 consist of the followings: SCHEDULE OF PROPERTY AND EQUIPMENT October 31, 2023 April 30, 2023 Computer equipment, software and furniture $ 224,303 $ 224,303 Less: accumulated depreciation (224,303 ) (224,303 ) Net property and equipment $ - $ - All equipment are fully depreciated as of October 31, 2023 and 2022. No additional investment in equipment for both fiscal years.

WARRANTS

WARRANTS	6 Months Ended
	Oct. 31, 2023
Warrants
WARRANTS	NOTE H – WARRANTS No warrants were issued to employees and or service providers.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE I – COMMITMENTS AND CONTINGENCIES Operating Lease Commitments Our executive offices are located in New York, NY. We have an agreement for use of office space at this location under a sub-lease which expired on July 31, 2018 and continues a month-to-month basis thereafter. The monthly base rent is $ 6,000 Rent expense was $ 18,000 16,350 Litigation The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. Sparta can make no representations about the potential outcome of such proceedings. As of October 31, 2023, we have not been named as parties to any further legal proceedings. The two litigations disclosed prior are updated below. From time to time, of course, we may become involved in further legal proceedings, which sometimes arise due to the very nature of and in the ordinary course of this business. By way of background, the Company had received notices dated April 1, 2016 and May 13, 2016, from a lender claiming defaults relating to conversion requests totaling $ 8,365 55,125 Concerning the above, on September 22, 2016, a motion for summary judgment in lieu of complaint was filed in the Supreme Court in the State of New York: County of Kings against the Company by a lender for the amount of $ 102,170.82 To date, no further Court appearances have been scheduled in this matter. However, most notably, a favorable decision from the New York State Court of Appeals regarding the same types of transactions has since determined such notes to be criminally usurious and, therefore, unenforceable. Since identical affirmative defenses were raised on behalf of the Company, the pending action is expected to be discontinued by plaintiff, with prejudice. Counsel for the parties have been working on a stipulation of discontinuance to that effect.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Oct. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE J – SUBSEQUENT EVENTS The Company has evaluated subsequent events for recognition and disclosure as of December 20, 2023 which is the date the financial statements were available to be issued. On December 14, 2023 a Stipulation of Discontinuance was filed in New York State Supreme Court: Kings County wherein the parties agreed to the discontinuance of any and all claims against the other with prejudice and with full waivers and releases. No other matters were identified affecting the accompanying financial statements and related disclosures.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Business	Business General Overview Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation with headquarters in New York City. We are a multi-disciplined parent corporation operating across three business sectors – Financial Services, E-Commerce & Mobile Technology, and Health and Wellness. Sparta’s roots are in the Powersports industry. The Company provided retail installment loans and leases through authorized motorcycle dealerships in 33 states, with financing lines of credit provided by institutional lenders. In 2007, the Company introduced a Municipal Financing program which has financed over 100 jurisdictions to date. Vehicle History Reports are a staple of Sparta’s E-Commerce Technology subsidiary iMobile Solutions, Inc. Whether a vehicle is intended for business or recreational use, Sparta’s Vehicle History Reports are highly regarded for accuracy and completeness and have been sold across all 50 states and in 62 countries worldwide. With iMobile App, the Company provides mobile technology services, including web and mobile application creation, development and management, text messaging services, CRM (Customer Relationship Management) tools, and custom kitchen ordering systems for a wide range of businesses to increase revenue, build brand recognition, and improve customer engagement. Sparta’s subsidiary, New World Health Brands, Inc., offers high quality dietary supplements Sparta’s subsidiary, Sparta Crypto, Inc., is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services; and has completed and tested a cryptocurrency payment gateway called SpartaPayIQ. Agoge Global USA, Inc. (“Agoge”). Agoge was formed as a subsidiary of Sparta Crypto, Inc. in December 2022 and entered in to a Joint Venture Agreement with WeDev Group of Brazil to facilitate cross-border transactions between importers and exporters of goods from the U.S. and Brazil.
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements as of October 31, 2023 and for the six months ended October 31, 2023 and 2022 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, including Form 10-Q and Regulation S-K. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments), which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. The Company believes that the disclosures provided are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and explanatory notes for the year ended April 30, 2023 as disclosed in the Company’s Form 10-K for that year as filed with the Securities and Exchange Commission on August 15, 2023. The results of operations for the six months ended October 31, 2023 are not necessarily indicative of the results to be expected for any other interim period or the full year ending April 30, 2023.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation. The third-party ownership of the Company’s subsidiary is accounted for as non-controlling interest in the consolidated financial statements. Changes in the non-controlling interest are reported in the statement of changes in deficit.
Estimates	Estimates These financial statements have been prepared in accordance with accounting principles generally accepted in United States of America which require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and the disclosures of revenues and expenses for the reported period. Accordingly, actual results could differ from those estimates.
Revenue Recognition	Revenue Recognition The Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions. Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.
Cash Equivalents	Cash Equivalents For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.
Fair Value Measurements	Fair Value Measurements The Company has adopted ASC 820, “Fair Value Measurements .” ● Level 1 — ● Level 2 — ● Level 3 — This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available.
Income Taxes	Income Taxes We utilize ASC 740 “ Income Taxes The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.
Stock Based Compensation	Stock Based Compensation We account for our stock-based compensation under ASC 718 “ Compensation – Stock Compensation We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.
Inventories	Inventories The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health business.
Property and Equipment	Property and Equipment Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows: SCHEDULE OF ESTIMATED USEFUL OF PROPERTY AND EQUIPMENT Leasehold improvements 3 years Furniture and fixtures 7 years Website costs 3 years Computer Equipment 5 years Estimated Useful of Property and Equipment 5 years
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.
Net Loss Per Share	Net Loss Per Share The Company uses ASC 260-10, “ Earnings Per Share
Derivative Liabilities	Derivative Liabilities The Company assessed the classification of its derivative financial instruments as of October 31, 2023 and April 30, 2023, which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.
Convertible Instruments	Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “ Accounting for Derivative Instruments and Hedging Activities The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “ Accounting for Convertible Securities with Beneficial Conversion Features
Reclassifications	Reclassifications Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses.
Recent Accounting Pronouncements	Recent Accounting Pronouncements No recent pronouncements have been made or adopted in the quarter ended October 31, 2023. All of the pronouncements that affect our business have been adopted.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
SCHEDULE OF ESTIMATED USEFUL OF PROPERTY AND EQUIPMENT	SCHEDULE OF ESTIMATED USEFUL OF PROPERTY AND EQUIPMENT Leasehold improvements 3 years Furniture and fixtures 7 years Website costs 3 years Computer Equipment 5 years Estimated Useful of Property and Equipment 5 years

NOTES PAYABLE AND DERIVATIVES (

NOTES PAYABLE AND DERIVATIVES (Tables)	6 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE	The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of 5 20 SCHEDULE OF NOTES PAYABLE Notes Payable October 31, 2023 April 30, 2023 Notes convertible at holder’s option $ 2,845,109 $ 3,112,734 Notes convertible at Company’s option 335,700 335,700 Non-convertible notes payable 2,383,308 1,861,650 Subtotal 5,564,117 5,310,084 Debt discount - - Total $ 5,564,117 $ 5,310,084
SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION	The change in fair value of the derivative liabilities at October 31, 2023 was calculated with the following average assumptions, using a Black-Scholes option pricing model are as follows: SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION Significant Assumptions: Risk free interest rate Ranging from 0.16 0.2 % Expected stock price volatility Ranging from 155 270 % Expected dividend payout 0 Expected life in years Ranging from 0.25 3.0
SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES	Changes in derivative liability during the three months ended October 31, 2023 and 2022 were: SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES 2023 2022 October 31, 2023 2022 Balance, beginning of year $ 1,375,767 $ 9,549,640 Derivative liability extinguished (100,797 ) (336,418 ) Fair value adjustments (76,576 ) (3,287,385 ) Balance, end of period 1,198,394 $ 5,925,387

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES	The table below summarizes the fair values of financial liabilities as of October 31, 2023: SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES Fair Value at Fair Value Measurement Using October 31, 2023 Level 1 Level 2 Level 3 Derivative liabilities $ 1,198,394 - - $ 1,198,394 Fair values of financial liabilities as of April 30, 2023 are as follows: Fair Value at Fair Value Measurement Using April 30, 2023 Level 1 Level 2 Level 3 Derivative liabilities $ 1,375,767 - - $ 1,375,767

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	6 Months Ended
	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	Major classes of property and equipment at October 31, 2023 and April 30, 2023 consist of the followings: SCHEDULE OF PROPERTY AND EQUIPMENT October 31, 2023 April 30, 2023 Computer equipment, software and furniture $ 224,303 $ 224,303 Less: accumulated depreciation (224,303 ) (224,303 ) Net property and equipment $ - $ -

SCHEDULE OF ESTIMATED USEFUL OF

SCHEDULE OF ESTIMATED USEFUL OF PROPERTY AND EQUIPMENT (Details)	Oct. 31, 2023
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful of Property and Equipment	3 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful of Property and Equipment	7 years
Website Costs [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful of Property and Equipment	3 years
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful of Property and Equipment	5 years

GOING CONCERN MATTERS (Details

GOING CONCERN MATTERS (Details Narrative) - USD ($)	Oct. 31, 2023	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 66,726,591	$ 66,150,857
Working capital deficit	$ 9,901,600

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Oct. 31, 2023	Apr. 30, 2023
Debt Instrument [Line Items]
Subtotal	$ 5,564,117	$ 5,310,084
Debt discount
Total	5,564,117	5,310,084
Notes Convertible At Holders Option [Member]
Debt Instrument [Line Items]
Subtotal	2,845,109	3,112,734
Notes Convertible At Companys Option [Member]
Debt Instrument [Line Items]
Subtotal	335,700	335,700
Non Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Subtotal	$ 2,383,308	$ 1,861,650
Minimum [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate	5%
Maximum [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate	20%

SCHEDULE OF DERIVATIVE LIABILIT

SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION (Details)	6 Months Ended
	Oct. 31, 2023
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	0.16
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	0.2
Measurement Input, Price Volatility [Member] | Minimum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	155
Measurement Input, Price Volatility [Member] | Maximum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	270
Measurement Input Dividend Payout [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	0
Measurement Input, Expected Term [Member] | Minimum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected life	3 months
Measurement Input, Expected Term [Member] | Maximum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected life	3 years

SCHEDULE OF CHANGES IN DERIVATI

SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details) - USD ($)	6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Debt Disclosure [Abstract]
Balance, beginning of year	$ 1,375,767	$ 9,549,640
Derivative liability extinguished	(100,797)	(336,418)
Fair value adjustments	(76,576)	(3,287,385)
Balance, end of period	$ 1,198,394	$ 5,925,387

NOTES PAYABLE AND DERIVATIVES_2

NOTES PAYABLE AND DERIVATIVES (Details Narrative)	6 Months Ended
	Oct. 31, 2023
Minimum [Member]
Debt Instrument [Line Items]
Common stock discount rate, percentage	30%
Maximum [Member]
Debt Instrument [Line Items]
Common stock discount rate, percentage	48%

LOANS PAYABLE TO RELATED PART_2

LOANS PAYABLE TO RELATED PARTIES (Details Narrative) - USD ($)	Oct. 31, 2023	Apr. 30, 2023
Related Party Transactions [Abstract]
Loans and notes payable	$ 631,163	$ 435,753

EQUITY TRANSACTIONS (Details Na

EQUITY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended				6 Months Ended
	Oct. 31, 2023	Jul. 31, 2023	Oct. 31, 2022	Jul. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Apr. 30, 2023
Class of Stock [Line Items]
Preferred stock, shares authorized	10,000,000				10,000,000		10,000,000
Preferred stock, par value	$ 0.001				$ 0.001		$ 0.001
Common stock, shares authorized	750,000,000				750,000,000		750,000,000
Common stock, par value	$ 0.001				$ 0.001		$ 0.001
Common stock shares issued	23,323,456				23,323,456		23,045,205
Common stock, shares, outstanding	23,323,456				23,323,456		23,045,205
Number of shares issued during period, value	$ 24,653	$ 69,169	$ 25,000	$ 44,646
Number of shares issued services, value	$ 3,875			$ 245,381
Sale of stock						134,805
Sale of stock value						$ 50,000
Four Accredited Investors [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares					1,178,251
Number of shares issued during period, value					$ 95,000
Consulting [Member]
Class of Stock [Line Items]
Number of shares issued services, shares					25,000	1,594,960
Number of shares issued services, value					$ 3,875
Incentive Noteholders [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares					75,000
Number of shares issued during period, value					$ 6,975
Five Accredited Investors [Member]
Class of Stock [Line Items]
Sale of stock					1,127,372
Sale of stock value					$ 85,000
Accredited Investors [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares						212,500
Post Split [Member]
Class of Stock [Line Items]
Common stock shares issued	24,323,456				24,323,456		23,045,205
Common stock, shares, outstanding	24,323,456				24,323,456		23,045,205
Series A Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	35,850				35,850		35,850
Preferred stock, par value	$ 100				$ 100		$ 100
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	1,000				1,000
Preferred stock, liquidation and redemption value per share	$ 10,000				$ 10,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	4,200,000				4,200,000		4,200,000
Preferred stock, par value	$ 0.001				$ 0.001		$ 0.001
Preferred stock, liquidation and redemption value per share	$ 1				$ 1		$ 1
Series D Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	2,000,000				2,000,000		2,000,000
Preferred stock, par value	$ 0.001				$ 0.001		$ 0.001
Preferred stock, liquidation and redemption value per share	$ 1				$ 1		$ 1
Series C Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Shares issued for conversion of shares, shares						641,000
Series D Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Shares issued for conversion of shares, shares						141,000

SCHEDULE OF FAIR VALUES OF FINA

SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details) - USD ($)	Oct. 31, 2023	Apr. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 1,198,394	$ 1,375,767
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 1,198,394	$ 1,375,767

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	Oct. 31, 2023	Apr. 30, 2023
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation	$ (224,303)	$ (224,303)
Net property and equipment
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Computer equipment, software and furniture	$ 224,303	$ 224,303

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended		6 Months Ended
	Sep. 22, 2016	May 13, 2016	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023
Rent expenses			$ 18,000	$ 16,350
Lender [Member]
Lender claiming amount		$ 8,365
Lender claiming total amount	$ 102,170.82	$ 55,125
Executive Office Space [Member]
Rent expenses					$ 6,000